Patents by Inventor Allan Wilcox

Allan Wilcox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060204563
    Abstract: The invention provides compositions, methods and kits for the removal of harmful or irritating substances from bodily surfaces. Kits may include a composition containing capsaicin and a capsaicin-cleaning composition, e.g., a composition in which capsaicin is soluble.
    Type: Application
    Filed: May 15, 2006
    Publication date: September 14, 2006
    Inventors: Arturo Angel, Larry Litle, Keith Bley, Allan Wilcox, Gene Jamieson, Naweed Muhammad
  • Publication number: 20060204564
    Abstract: The invention provides compositions, methods and kits for the removal of harmful or irritating substances from bodily surfaces. Kits may include a composition containing capsaicin and a capsaicin-cleansing composition, e.g., a composition in which capsaicin is soluble.
    Type: Application
    Filed: May 15, 2006
    Publication date: September 14, 2006
    Inventors: Arturo Angel, Larry Litle, Keith Bley, Allan Wilcox, Gene Jamieson, Naweed Muhammad
  • Publication number: 20060100461
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Application
    Filed: December 16, 2005
    Publication date: May 11, 2006
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 7005546
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: June 22, 2004
    Date of Patent: February 28, 2006
    Assignee: Renovis, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Publication number: 20050124691
    Abstract: Disclosed are novel ?-aryl-N-alkylnitrone compounds and pharmaceutical compositions containing such compounds. The disclosed compositions are useful as therapeutics for preventing and/or treating neurodegenerative, autoimmune and inflammatory conditions in mammals and as analytical reagents for detecting free radicals.
    Type: Application
    Filed: March 5, 2004
    Publication date: June 9, 2005
    Inventors: Judith Kelleher, Kirk Maples, Alina Dykman, Yong-Kang Zhang, Allan Wilcox, Julian Levell
  • Publication number: 20040266881
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Application
    Filed: June 22, 2004
    Publication date: December 30, 2004
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 6759433
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: July 6, 2004
    Assignee: Renovis, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 6689911
    Abstract: An integrated process for preparing &agr;-(2,4-disulfophenyl)-N-tert-butylnitrone and its salts is disclosed in which N-tert-butylhydroxylamine acid addition salt is incompletely neutralised so as to leave catalytic amounts of acid and the neutralisation product is condensed with an appropriate aldehyde.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: February 10, 2004
    Assignees: Centaur Pharmaceuticals, Inc., AstraZeneca AB
    Inventors: Henry Kruk, John McGinley, Sergei Pouhov, John Vajda, Allan Wilcox, J├Ârgen Blixt, Ulf Larsson
  • Publication number: 20030176510
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Application
    Filed: December 12, 2002
    Publication date: September 18, 2003
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Publication number: 20030069442
    Abstract: An integrated process for preparing &agr;-(2,4-disulfophenyl)-N-tert-butylnitrone and its salts is disclosed in which N-tert-butylhydroxylamine acid addition salt is incompletely neutralised so as to leave catalytic amounts of acid and the neutralisation product is condensed with an appropriate aldehyde.
    Type: Application
    Filed: April 5, 2001
    Publication date: April 10, 2003
    Inventors: Henry Kruk, John McGinley, Sergei Pouhov, John Vajda, Allan Wilcox, Jorgen Blixt, Ulf Larsson
  • Patent number: 6509378
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: January 21, 2003
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Publication number: 20010037040
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Application
    Filed: April 30, 2001
    Publication date: November 1, 2001
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 6077870
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: June 20, 2000
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 6066765
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: March 30, 1998
    Date of Patent: May 23, 2000
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 5914350
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: January 10, 1997
    Date of Patent: June 22, 1999
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 5907061
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: May 25, 1999
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 5756548
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: May 26, 1998
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 5659082
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: August 19, 1997
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 5658953
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: August 19, 1997
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • Patent number: 5643965
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: July 1, 1997
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox